This certainly will be an engaging conversation. Providers
are facing pressure from within and outside the field to address practices that
may not only be unethical, but criminal. Payments to interventionists, transparency
in marketing programs, and honest discussions with families and patients about
what insurance will--and will not pay--are among the issues the panelists will
discuss. I welcome your input in the comments section below on other topics
that should be addressed during the discussion.
Parity and the Affordable Care Act open up the field to more
reimbursement opportunities. But with those dollars comes greater scrutiny, and
we all know there are treatment providers whose marketing practices are
damaging to the entire field. At the same time, however, there are many gray
areas in which the right direction is not as clear cut. This panel discussion,
and continuing dialogue within organizations and at the national level, is
essential to ensure that the addiction treatment field is on sound ethical
footing as it becomes a greater component of the overall healthcare system.